American Heart Journal
Volume 147, Issue 3 , Pages 546-552 , March 2004

Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis

  • Michael P Hudson, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • Corresponding Author InformationReprint requests: Michael Hudson, MD, MHS, Henry Ford Hospital, K-14, 2799 West Grand Blvd, Detroit, MI 48202, USA.
    • ,
  • Christopher M O'Connor, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Wendy A Gattis, RPH

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Gudaye Tasissa, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Vic Hasselblad, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Cathy M Holleman, MS

      Affiliations

    • Division of Cardiology, Department of Laboratory Medicine, Duke University Medical Center, Durham, NC, USA
    • ,
  • Laura H Gaulden, MS

      Affiliations

    • Division of Cardiology, Department of Laboratory Medicine, Duke University Medical Center, Durham, NC, USA
    • ,
  • Frank Sedor, PhD

      Affiliations

    • Division of Cardiology, Department of Laboratory Medicine, Duke University Medical Center, Durham, NC, USA
    • ,
  • E.Magnus Ohman, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA

Received 24 June 2003 ,Accepted 3 October 2003.

References 

  1. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Circulation. 1993;88:750–763
  2. Muller-Bardorff M, Hallermayer K, Schroder A, et al.  Improved troponin T ELISA specific for cardiac troponin T isoform (assay development and analytical and clinical validation). Clin Chem. 1997;43:458–466
  3. Gerhardt W, Ljungdahl L, Herbert AK. Troponin-T and CK-MB in early diagnosis of ischemic myocardial injury (the Helsingborg Study, 1992). Clin Biochem. 1993;26:231–240
  4. Jaffe AS, Ravkilde J, Roberts R, et al.  It's time for a change to a troponin standard. Circulation. 2000;102:1216–1220
  5. Antman EM, Tanasijevic NJ, Thompson B, et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349
  6. Ohman EM, Armstrong PW, Christenson RH, et al.  Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333–1341
  7. Olatidoye AG, Wu AHB, Feng YJ, et al.  Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol. 1998;81:1405–1410
  8. Lindahl B, Diderholm E, Lagerqvist B, et al.  Effect on mortality by LMW heparin in relation to STT changes and level of troponin T in unstable coronary artery disease—a FRISC II substudy. Circulation. 2000;102:II-826
  9. Lopez-Jimenez F, Goldman L, Sacks DB, et al.  Prognostic value of cardiac troponin T after noncardiac surgery (6-month follow-up data). J Am Coll Cardiol. 1997;29:1241–1245
  10. Cardinale D, Sandri MT, Martinoni E, et al.  Left ventricular dysfunction predicted by early troponin I release after high dose chemotherapy. J Am Coll Cardiol. 2000;36:517–522
  11. Parekh N, Venkatesh B, Cross D, et al.  Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36:1328–1335
  12. Dierkes J, Domrose U, Westphal S, et al.  Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation. 2000;102:1964–1969
  13. Missov E, Mair J. A novel biochemical approach to congestive heart failure (cardiac troponin T). Am Heart J. 1999;138:95–99
  14. La Vecchia L, Mezzena G, Ormetto R, et al.  Detectable serum troponin I in patients with heart failure of nonmyocardial ischemia origin. Am J Cardiol. 1997;80:87–90
  15. Setsuta K, Seino Y, Takahashi N, et al.  Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol. 1999;84:608–611
  16. Missov ED, DeMarco T. Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chem Acta. 1999;284:175–185
  17. Davies CH, Harding SE, Poole-Wilson PA. Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J. 1996;17:189–198
  18. Narula J, Haider N, Virmani R, et al.  Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182–1189
  19. Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatinine kinase, creatinine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem. 2000;46:338–344
  20. Del Carlo CH, O'Connor CM. Cardiac troponins in congestive heart failure. Am Heart J. 1999;138:646–653
  21. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 1997;96:2953–2958
  22. Sato Y, Yamada T, Taniguchi R, et al.  Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 2001;103:369–374
  23. The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction . Myocardial infarction redefined. J Am Coll Cardiol. 2000;36:959–969
  24. Morrow DA, Cannon CP, Rifai N, et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA. 2001;286:2405–2412

☆ Supported by a research grant from Roche Diagnostics, Indianapolis, Ind.Guest Editor for this manuscript was Charles Maynard, PhD, University of Washington, Seattle, Wash.

PII: S0002-8703(03)00725-7

doi: 10.1016/j.ahj.2003.10.014

American Heart Journal
Volume 147, Issue 3 , Pages 546-552 , March 2004

Article Tools

* Image Usage & Resolution